Kinomica

Macclesfield, United Kingdom Founded: 2017 • Age: 9 yrs
Bioinformatics platform for precision medicine development is offered.
Request Access

About Kinomica

Kinomica is a company based in Macclesfield (United Kingdom) founded in 2017 by John Gribben, Pedro Cutillas, and David Britton.. Kinomica has raised $5.16 million across 2 funding rounds from investors including Alderley Park, BioCity and BGF. The company has 13 employees as of June 30, 2021. Kinomica offers products and services including KScan®. Kinomica operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.

  • Headquarter Macclesfield, United Kingdom
  • Employees 13 as on 30 Jun, 2021
  • Founders John Gribben, Pedro Cutillas, David Britton
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Kinomica Limited
  • Date of Incorporation 01 Oct, 2016
  • Jurisdiction MACCLESFIELD, CHESHIRE, ENGLAND
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.16 M (USD)

    in 2 rounds

  • Latest Funding Round
    $5.16 M (USD), Series A

    Dec 14, 2020

  • Investors
  • Employee Count
    13

    as on Jun 30, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kinomica

Kinomica offers a comprehensive portfolio of products and services, including KScan®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Analyzes protein phosphorylation for cancer treatment selection and precision medicine.

People of Kinomica
Headcount 1-10
Employee Profiles 4
Employee Profiles
People
Andrew J. Thompson
Program Director
People
Arran Dokal
Chief Technology Officer
People
Weronika Borek, PhD
Bioinformatics Technical Lead

Unlock access to complete

Teams

Funding Insights of Kinomica

Kinomica has successfully raised a total of $5.16M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.16 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $5.2M
  • First Round
  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2020 Amount Series A - Kinomica Valuation BGF , Longwall Venture Partners
Aug, 2019 Amount Seed - Kinomica Valuation BioCity
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kinomica

Kinomica has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Alderley Park, BioCity and BGF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
Founded Year Domain Location
Early-stage deeptech businesses are supported through venture capital investments.
Founded Year Domain Location
Life Science focused startup accelerator and incubator
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kinomica

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kinomica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kinomica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kinomica

Kinomica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
domain founded_year HQ Location
Gene therapies for rare diseases including retinal dystrophies are developed.
domain founded_year HQ Location
RNA interference-based therapeutics are developed for multiple disorders.
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
domain founded_year HQ Location
Therapeutics for rare and ultra-rare metabolic diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kinomica

Frequently Asked Questions about Kinomica

When was Kinomica founded?

Kinomica was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Where is Kinomica located?

Kinomica is headquartered in Macclesfield, United Kingdom. It is registered at Macclesfield, Cheshire, United Kingdom.

Who is the current CEO of Kinomica?

Jane Theaker is the current CEO of Kinomica.

Is Kinomica a funded company?

Kinomica is a funded company, having raised a total of $5.16M across 2 funding rounds to date.

How many employees does Kinomica have?

As of Jun 30, 2021, the latest employee count at Kinomica is 13.

What does Kinomica do?

Kinomica was founded in 2017 and is headquartered in Macclesfield, United Kingdom. A bioinformatics platform is provided by the company within the precision medicine sector. Proprietary bioinformatics and LC-MSMS phospho-proteomics are utilized to examine cellular signaling activities and biochemical network changes. Applications encompass the study of disease mechanisms, identification of drug targets and biomarkers, assessment of drug efficacy, and determination of therapy responders.

Who are the top competitors of Kinomica?

Kinomica's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.

What products or services does Kinomica offer?

Kinomica offers KScan®.

Who are Kinomica's investors?

Kinomica has 5 investors. Key investors include Alderley Park, BioCity, BGF, Longwall Ventures, and Puffin Point.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available